For Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need a reliable cytokine source for cell‑culture, immunology, or hematopoiesis research, Global Technology Co., Ltd delivers GMP‑grade GM‑CSF with ≤0.1 EU/mg endotoxin, certified activity, and next‑day shipping from the USA hub.
Get Free Quote in 24 hWhen you invest thousands of dollars in cell‑culture experiments, any inconsistency in cytokine quality translates directly into wasted reagents, delayed timelines, and unreliable data. Below are the three most common pain points reported by U.S. biotech firms in 2025:
These issues are not just cost problems; they erode scientific credibility and delay product pipelines, which can cost up to 15 % of annual R&D budgets in lost opportunity.
Global Technology Co., Ltd leverages a state‑of‑the‑art recombinant protein platform that combines CHO‑cell expression, proprietary purification, and strict GMP compliance. The result is a product that meets the highest regulatory standards while staying cost‑effective.
| Parameter | Specification |
|---|---|
| Product Name | GM‑CSF (Granulocyte‑Macrophage Colony‑Stimulating Factor) |
| CAS No. | 313219‑94‑2 |
| Expression System | CHO Cells (Mammalian) – ensures native glycosylation |
| Purity (HPLC) | ≥95 % |
| Endotoxin | ≤0.1 EU/mg |
| Activity (bioassay) | ≥10 × 10⁶ U/mg (NIH‑3T3 assay) |
| Form | Lyophilized powder / Sterile liquid (1 mg/mL) |
| Stability | ≤24 months at –20 °C (dry) / ≤12 months at 4 °C (solution) |
| Packaging | Cryovial (0.5 mL), ampoule, bulk bag (up to 5 kg) |
| Certificates | FDA, EMA, ISO 9001, GMP, CE, RoHS |
1. Hematopoietic Stem Cell Expansion – A U.S. biotech startup reduced colony‑forming unit‑granulocyte (CFU‑G) variability from 27 % to 4 % after switching to our low‑endotoxin GM‑CSF, accelerating IND filing by 3 months.
2. Immunotherapy Research – An academic lab reported a 35 % increase in dendritic‑cell yield when using our GMP‑grade protein versus a non‑GMP competitor, leading to a high‑impact publication in *Nature Immunology*.
3. Large‑Scale Manufacturing – A contract manufacturing organization (CMO) ordered 2 kg for a Phase II trial; we delivered within 10 days, saving them $5,800 in freight compared with Chinese suppliers.
EGFR-MET-dual-inhibitor-mutation-research Argipressin-Acetate-for-Critical-Care-Drugs Androstenedione Adaliumab
All batches are accompanied by a full Certificate of Analysis (CoA) and meet the following standards:
Standard orders ship within 48 hours after payment confirmation. Expedited shipping (next‑day) is available for an additional $150.
Yes. Our OEM/ODM service includes sterile‑filtered solutions, customized vial sizes, and bulk‑bag packaging. Minimum order for custom liquid is 100 mg.
We employ a two‑step anion‑exchange chromatography followed by ultrafiltration. Every batch is tested by LAL assay; results are documented on the CoA.
We accept T/T (SWIFT), PayPal, and corporate credit cards. For first‑time buyers, a 30 % deposit secures production, with the balance due before shipment.

All GMP‑grade batches come with FDA‑compliant certificates, GMP batch records, and a full analytical dossier suitable for IND submissions.
Limited‑time Offer: Order now and receive a **free 5 mg sample** plus a **money‑back guarantee** if the activity falls below the stated specification.
Request Free Sample Contact Sales (WhatsApp +86‑199‑4383‑0844)Offer valid until June 30 2026. Stock is limited to 10 kg of GMP‑grade GM‑CSF per month.
Dr. Alan Murphy, Immunology Lead, Apex Biotech – “The low‑endotoxin profile eliminated the need for additional detox steps, cutting our prep time by **45 %**.”
Sara Liu, Procurement Manager, NovaPharm – “Transparent pricing and the **48‑hour dispatch** saved us $3,200 in freight compared with our previous Asian supplier.”
James O’Connor, CTO, CellMatrix – “OEM‑customized sterile solution arrived ready for our GMP‑run. The product passed our validation on the first attempt – a **100 % success rate**.”
Contact Information
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Privacy Policy: All inquiries are handled in accordance with GDPR and CCPA regulations.